Risk factors for adverse outcome in patients with Chronic Lymphocytic Leukemia (CLL) undergoing Allogeneic Hematopoietic Cell Transplantation (alloHCT): A Retrospective EBMT Analysis

被引：0
|
作者：
Schetelig, J. [1 ,2 ,3 ]
de Wreede, L. [4 ]
Moreno, C. [5 ]
Andersen, N. Smedegaard [6 ]
van Gelder, M. [7 ]
Machaczka, M. [8 ]
Gramatzki, M. [9 ]
Dreger, P. [10 ]
Vitek, A. [11 ]
Karas, M. [12 ]
Michallet, M. [13 ]
Henseler, A. [4 ]
Bornhaeuser, M. [1 ,2 ]
Schoenland, S. [10 ]
Kroeger, N. [14 ]
机构：
[1] Tech Univ Dresden, Univ Hosp, Med Dept 1, D-01062 Dresden, Germany
[2] DKMS Clin Trials Unit, Dresden, Germany
[3] German Bone Marrow Donor Ctr Germany, DKMS, Tubingen, Germany
[4] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands
[5] Hosp Santa Creu & Sant Pau, Hematol, Barcelona, Spain
[6] Rigshosp, Dept Hematol, BMT Unit, DK-2100 Copenhagen, Denmark
[7] Univ Med Ctr Maastricht, Maastricht, Netherlands
[8] Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden
[9] Univ Hosp Schleswig Holstein, Div Stem Cell Transplantat & Immunotherapy, Kiel, Germany
[10] Heidelberg Univ, Med Klin & Poliklin 5, Heidelberg, Germany
[11] Inst Hematol & Blood Transfus, Dept Haematol, CR-12820 Prague, Czech Republic
[12] Charles Univ Hosp, Dept Hematol Oncol, Plzen, Czech Republic
[13] Ctr Hosp Lyon Sud, Hematol, Lyon, France
[14] Univ Hosp Eppendorf, Bone Marrow Transplantat Ctr, Hamburg, Germany
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
WP024
引用
收藏
页码：S107 / S108
页数：2
相关论文
共 50 条
  • [1] Allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia (CLL) with 17p deletion: A retrospective EBMT analysis
    Schetelig, Johannes
    van Biezen, Anja
    Caballero, Dolores
    Rodrigo, Martino
    Remes, Kari
    Garcia-Marco, Jose A.
    Volin, Liisa
    Perez-Simon, Jose A.
    Schmitz, Norbert
    Schwerdtfeger, Rainer
    Ganser, Arnold
    Soligo, Davide
    Mohr, Brigitte
    Stilgenbauer, Stephan
    Brand, Ronald
    Ehninger, Gerhard
    de Witte, Theo
    Dreger, Peter
    [J]. BLOOD, 2007, 110 (11) : 22A - 23A
  • [2] The 10-years EBMT Landscape of Allogeneic Hematopoietic Cell Transplantation (Allohct) for Chronic Lymphocytic Leukemia
    Tournilhac, Olivier
    van Gelder, Michel
    Dreger, Peter
    Bornhaeuser, Martin
    Platzbecker, Uwe
    Scheid, Christof
    Beelen, Dietrich
    Jindra, Pavel
    Cornelissen, Jan J.
    Sengeloev, Henrik
    Nguyen, Stephanie
    Mayer, Jiri
    Stelljes, Matthias
    Dilhuydy, Marie-Sarah
    Griskevicius, Laimonas
    Vitek, Antonin
    Nikolousis, Manos
    Kroeger, Nicolaus
    Hellmann, Andrzej
    Santarone, Stella
    Zinger, Nienke
    Hayden, Patrick
    Yakoub-Agha, Ibrahim
    [J]. BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 60 - 60
  • [3] T-Cell Depletion in Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia: A Retrospective EBMT Analysis
    Schetelig, Johannes
    Milligan, Donald
    Niederwieser, Dietger
    Volin, Liisa
    Maertens, J.
    Gratwohl, Aolis
    Bornhaeuser, Martin
    Van Gelder, Michel
    Brand, Ronald
    de Witte, T. M.
    Dreger, Peter
    [J]. BLOOD, 2009, 114 (22) : 911 - 911
  • [4] Bridging with Idelalisib appears safe in patients with chronic lymphocytic leukemia (CLL) prior to allogeneic hematopoietic stem cell transplantation (alloHCT): A Report from the EBMT Chronic Malignancies Working Party
    Schetelig, J.
    Chevallier, P.
    van Gelder, M.
    Hoek, J.
    Hermine, O.
    Thomson, K.
    Browne, P.
    Milpied, N.
    Russo, D.
    Socie, G.
    Rovira, M.
    Deconinck, E.
    Damaj, G.
    Cordonnier, C.
    Beelen, D.
    Leblond, V.
    Nikolousis, M.
    Stuhler, G.
    Mayer, J.
    Hunault-Berger, M.
    Bittenbring, J.
    Thieblemont, C.
    Lepetre, S.
    de Wreede, L. C.
    Dreger, P.
    Kroeger, N.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S99 - S100
  • [5] Outcome Of Chronic Lymphocytic Leukemia (CLL) Patients That Failed Allogeneic Stem Cell Transplantation
    Benjamini, Ohad
    Rozovski, Uri
    Jain, Preetesh
    Wierda, William G.
    O'Brien, Susan
    Burger, Jan A.
    Ferrajoli, Alessandra
    Faderl, Stefan H.
    Shpall, Elizabeth J.
    Hosing, Chitra M.
    Khouri, Issa F.
    Champlin, Richard E.
    Keating, Michael J.
    Estrov, Zeev
    [J]. BLOOD, 2013, 122 (21)
  • [6] Outcome of Chronic Lymphocytic Leukemia (CLL) Patients That Failed Allogeneic Stem Cell Transplantation
    Benjamini, Ohad
    Rozovski, Uri
    Jain, Preetesh
    Wierda, William G.
    O'Brien, Susan
    Burger, Jan
    Ferrajoll, Alessandra
    Faderl, Stefan
    Shpall, Elizabeth
    Hosing, Chitra
    Khouri, Issa F.
    Champlin, Richard
    Keating, Michael J.
    Estrov, Zeev
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S130 - S131
  • [7] Safety and Efficacy of Idelalisib Treatment of Chronic Lymphocytic Leukemia (CLL) or Lymphoma Relapsing after Allogeneic Hematopoietic Cell Transplantation (alloHCT): A Survey By the EBMT Chronic Malignancies and Lymphoma Working Parties
    Dreger, Peter
    Koster, Linda
    Passweg, Jakob R.
    Collin, Matthew
    Scheid, Christof
    Charbonnier, Amandine
    Ciceri, Fabio
    Thieblemont, Catherine
    Wolff, Daniel
    Bittenbring, Joerg
    Gribben, John
    Porras, Rocio Parody
    Isaksson, Cecilia
    Hunault, Mathilde
    Corradini, Paolo
    Doubek, Michael
    Kobbe, Guido
    Bazarbachi, Ali
    Wilson, Keith
    Cahn, Jean Yves
    Leblond, Veronique
    Kroger, Nicolaus
    Montoto, Silvia
    Schetelig, Johannes
    [J]. BLOOD, 2017, 130
  • [8] Prognostic factors for survival after autologous and allogeneic stem cell transplantation for Chronic Lymphocytic Leukemia (CLL): The EBMT experience
    Michallet, M
    Brand, R
    Dreger, P
    Milligan, DW
    Esteve, J
    Kimby, E
    Gratwohl, A
    Apperley, J
    Van Biezen, A
    Niederwieser, D
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S31 - S31
  • [9] ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) IN CHEMOTHERAPY REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Aljitawi, O. S.
    Krishnana, A.
    Nademance, A.
    Palmer, J.
    Alvarnas, J.
    Cai, J. -L.
    Kirschbaum, M.
    Kogut, N.
    Nakamura, R.
    Popplewell, L.
    Sarkodee-Adoo, C.
    Schriber, J.
    Zain, J.
    Parker, F.
    Forman, P.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 109 - 109
  • [10] Allogeneic hematopoietic stem cell transplantation (HSCT) for chronic lymphocytic leukemia (CLL): Results and prognostic factors for survival after transplantation. Analysis from EBMT registry.
    Michallet, M
    Brand, R
    Dreger, P
    Millighan, D
    Esteve, J
    Kimby, E
    Apperley, J
    Van Biezen, A
    Niederwieser, D
    [J]. BLOOD, 2000, 96 (11) : 205A - 205A
12345